S. 2355

S. 2355: Patients Deserve Price Tags Act

Reported by Committee Roger Marshall (R) SENATE_BILL — 119th Congress
Plain English Summary

The Patients Deserve Price Tags Act aims to enhance price transparency in healthcare by requiring medical providers to disclose the costs of services and treatments upfront. This legislation is likely intended to empower patients to make informed decisions about their healthcare options by knowing the financial implications before receiving care.

Positive Media Summary

Supporters of the Patients Deserve Price Tags Act have praised it as a significant step towards healthcare reform, emphasizing that it promotes consumer rights and allows patients to shop for better prices, potentially lowering overall healthcare costs. Advocates argue that increased transparency can lead to better health outcomes and more competitive pricing in the medical industry.

Negative Media Summary

Critics of the Patients Deserve Price Tags Act have expressed concerns that it may not adequately address the complexities of healthcare pricing and could overwhelm patients with information. Some have argued that simply providing price tags does not guarantee affordability or quality of care and that the legislation may not effectively reduce healthcare costs in practice.

Conflict of Interest Analysis Deep Analysis
3/10
Risk Level
Low
Total Donations
$0
PAC Percentage
0%
Policy Area
Health

While there are no direct industry overlaps between the bill's subject matter and the sponsor's top donor industries, the lobbying activity associated with this bill reveals potential areas of concern. Notably, Saildrone Inc. has contributed significant amounts ($410,042 and $377,725) and is involved in advanced technology, which could intersect with healthcare technology discussions in the Patients Deserve Price Tags Act. Additionally, the presence of various lobbying groups, such as the Environmental Defense Fund and Seeing Machines, indicates a diverse range of interests that may not align directly with the bill's intent but could influence legislative outcomes. Voters should be aware that while direct conflicts are not apparent, the financial influence of these donors and lobbyists could shape the bill's provisions in ways that may not prioritize patient interests.

Lobbying Activity — Who's Pushing?

Organizations that lobbied on issues related to this bill's policy area.

Client Lobbying Firm Amount
SAILDRONE INC. SAILDRONE INC. $410,042
SAILDRONE INC. SAILDRONE INC. $377,725
OUTDOOR ADVERTISING ASSOCIATION OF AMERICA INC OUTDOOR ADVERTISING ASSOCIATION OF AMERICA, INC. $158,589
INTERNATIONAL LONGSHOREMEN'S ASSOCIATION INTERNATIONAL LONGSHOREMEN'S ASSOCIATION $150,000
SBIR CONSORTIUM JOHN WILLIAMS $30,000
ENVIRONMENTAL DEFENSE FUND BOUNDARY STONE PARTNERS $30,000
SEEING MACHINES GRIFFIN STRATEGIES, LLC $30,000
SAFE KIDS WORLDWIDE GRIFFIN STRATEGIES, LLC $30,000
CREATIVE ASSOCIATES INTERNATIONAL, INC. DEFENDING OUR COUNTRY, LLC $30,000
MIDDLE EAST FORUM MIDDLE EAST FORUM $20,000
ATA ACTION RS GROUP CONSULTING LLC $6,000
END SEPSIS CURRENTSTRATEGIC LLC undisclosed
TECHNEST SOLUTIONS S.L.A. DBA FORTRIS ON BEHALF OF NEXUSONE CONSULTING CURRENTSTRATEGIC LLC undisclosed
SBCC EQUIPMENT DEFENDING OUR COUNTRY, LLC undisclosed
BAXTER HEALTHCARE CORPORATION SUMMIT HEALTH CARE CONSULTING undisclosed

Source: Senate Lobbying Disclosure Act (LDA) filings, 2026

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us